Article
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease.
Stem cells translational medicine - 1 Sept 2020
Losurdo Morris, Pedrazzoli Matteo, D'Agostino Claudia, Elia Chiara A, Massenzio Francesca, Lonati Elena, Mauri Mario, Rizzi Laura, Molteni Laura, Bresciani Elena, Dander Erica, D'Amico Giovanna, Bulbarelli Alessandra, Torsello Antonio, Matteoli Michela, Buffelli Mario, Coco Silvia
Abstract excerpt
The critical role of neuroinflammation in favoring and accelerating the pathogenic process in Alzheimer's disease (AD) increased the need to target the cerebral innate immune cells as a potential therapeutic strategy to slow down the disease progression. In this scenario, mesenchymal stem cells (MSCs) have risen considerable interest thanks to their immunomodulatory properties, which have been largely ascribed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
